The Role of Cardiovascular Risk Prediction Model Selection in Primary Prevention: An Observational Study of Statin Eligibility Agreement Across Nine Scores in a Lithuanian Primary-Prevention Cohort
Medicina · 17.05.2026 · 62 (5) · 979
DOI: 10.3390/medicina62050979 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medicina, online erschienen am 17.05.2026. Verfasst von Petras Navickas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiovascular Diseases, Primary Prevention. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charity Fund Future Biomedicine Fund, Gediminas Gruodis donation.
Abstract (Originalsprache)
Background and Objectives: Cardiovascular risk prediction models (RPMs) are widely used to guide statin initiation in primary prevention, yet the extent to which different models produce concordant treatment decisions in the same population remains insufficiently characterized. We compared statin eligibility across nine commonly used RPMs: SCORE2, PREVENT, PCE, ASSIGN, FRS-hCHD, AusCVDRisk, MESA, QRISK3, and RRS. Materials and Methods: We performed a cross-sectional analysis of 11,174 adults aged 40–65 years with metabolic syndrome enrolled in the Lithuanian High Cardiovascular Risk primary prevention program (LitHiR) and evaluated them at a single tertiary center during 2006–2023. Statin eligibility was determined for each RPM using guideline-mapped treatment thresholds. Pairwise agreement was assessed using Cohen’s κ, Gwet’s AC1, Positive and Negative Percent Agreement (PPA/NPA), the Jaccard index, and McNemar testing. Analyses were repeated by sex. Consensus eligibility was defined as treatment recommended by at least k of nine models.
Results
Eligibility varied more than twenty-fold, from 67.39% (7530/11,174) with SCORE2 to 3.03% (339/11,174) with AusCVDRisk; intermediate estimates included PREVENT at 44.83%, QRISK3 at 39.00%, and PCE at 37.97%. Overall pairwise agreement was modest: κ ranged from 0.03 (SCORE2 vs. AusCVDRisk) to 0.67 (QRISK3 vs. ASSIGN), with a median κ of 0.38 (IQR: 0.19–0.51). Median AC1 was 0.58 (IQR 0.37–0.68). Agreement was stronger for non-eligibility than for eligibility (median NPA: 0.82 vs. median PPA: 0.53). Consensus eligibility declined from 73.5% at k = 1 to 45.1% at k = 3, 30.0% at k = 5, and 1.87% at k = 9, with the greatest sex divergence at intermediate stringency.
Conclusions
In this real-world cohort with elevated cardiometabolic risk, statin eligibility was highly dependent on RPM choice and showed only modest inter-model concordance. Increasing consensus stringency rapidly reduced eligibility, indicating that RPM selection and embedded thresholds substantially influence statin treatment decisions in primary prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.
- State Research Institute Centre for Innovative Medicine, LT-08406 Vilnius, Lithuania.
ORCID-Profile: Petras Navickas, Sigita Glaveckaitė, Agnė Šatrauskienė, Arvydas Baranauskas, Egidija Rinkūnienė, Vaida Šileikienė, Aleksandras Laucevičius
Förderung
- Charity Fund Future Biomedicine Fund
- Gediminas Gruodis donation
Zitieren
APA
Navickas, P., Glaveckaitė, S., Lukavičiūtė-Navickienė, L., Šatrauskienė, A., Baranauskas, A., Rinkūnienė, E., Meškėnė, E., Šileikienė, V., Lycholip, E., & Laucevičius, A. (2026). The Role of Cardiovascular Risk Prediction Model Selection in Primary Prevention: An Observational Study of Statin Eligibility Agreement Across Nine Scores in a Lithuanian Primary-Prevention Cohort. Medicina, 62(5), 979. https://doi.org/10.3390/medicina62050979
Vancouver
Navickas P, Glaveckaitė S, Lukavičiūtė-Navickienė L, Šatrauskienė A, Baranauskas A, Rinkūnienė E, et al. The Role of Cardiovascular Risk Prediction Model Selection in Primary Prevention: An Observational Study of Statin Eligibility Agreement Across Nine Scores in a Lithuanian Primary-Prevention Cohort. Medicina. 2026;62(5):979. doi:10.3390/medicina62050979
BibTeX
@article{Navickas2026,
author = {Navickas, Petras and Glaveckaitė, Sigita and Lukavičiūtė-Navickienė, Laura and Šatrauskienė, Agnė and Baranauskas, Arvydas and Rinkūnienė, Egidija and Meškėnė, Emilija and Šileikienė, Vaida and Lycholip, Edita and Laucevičius, Aleksandras},
title = {The Role of Cardiovascular Risk Prediction Model Selection in Primary Prevention: An Observational Study of Statin Eligibility Agreement Across Nine Scores in a Lithuanian Primary-Prevention Cohort},
journal = {Medicina},
year = {2026},
volume = {62},
number = {5},
pages = {979},
doi = {10.3390/medicina62050979}
}
EUVIMED